KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Change in Cash (2016 - 2025)

Medpace Holdings' Change in Cash history spans 11 years, with the latest figure at $211.7 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 1588.72% year-over-year to $211.7 million; the TTM value through Dec 2025 reached -$172.4 million, down 140.66%, while the annual FY2025 figure was -$172.4 million, 140.66% down from the prior year.
  • Change in Cash reached $211.7 million in Q4 2025 per MEDP's latest filing, down from $239.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $239.0 million in Q3 2025 to a low of -$395.1 million in Q2 2025.
  • Average Change in Cash over 5 years is $11.0 million, with a median of $36.9 million recorded in 2021.
  • Peak YoY movement for Change in Cash: plummeted 786.72% in 2022, then soared 5579.29% in 2023.
  • A 5-year view of Change in Cash shows it stood at $62.9 million in 2021, then plummeted by 104.36% to -$2.7 million in 2022, then skyrocketed by 5579.29% to $150.2 million in 2023, then crashed by 91.66% to $12.5 million in 2024, then soared by 1588.72% to $211.7 million in 2025.
  • Per Business Quant, the three most recent readings for MEDP's Change in Cash are $211.7 million (Q4 2025), $239.0 million (Q3 2025), and -$395.1 million (Q2 2025).